These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20008092)

  • 1. Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
    Tanaka T; Hagihara K; Shima Y; Narazaki M; Ogata A; Kawase I; Kishimoto T
    Rheumatology (Oxford); 2010 Apr; 49(4):824-6. PubMed ID: 20008092
    [No Abstract]   [Full Text] [Related]  

  • 2. Steroid-resistant remitting seronegative symmetrical synovitis with pitting oedema associated with gout treated with etanercept.
    Mehta P; Chong S; Carulli MT; Haskard DO
    Rheumatology (Oxford); 2014 Oct; 53(10):1908-10. PubMed ID: 24907150
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
    Tanaka T; Kuwahara Y; Shima Y; Hirano T; Kawai M; Ogawa M; Arimitsu J; Hagihara K; Narazaki M; Ogata A; Kawase I; Kishimoto T
    Arthritis Rheum; 2009 Dec; 61(12):1762-4. PubMed ID: 19950316
    [No Abstract]   [Full Text] [Related]  

  • 4. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) associated with psoriatic arthritis.
    Kardes S; Karagulle M; Erdogan N
    Scand J Rheumatol; 2015; 44(4):339-40. PubMed ID: 25958968
    [No Abstract]   [Full Text] [Related]  

  • 5. [Remittent seronegative symmetrical synovitis with pitting edema].
    Lilleby V; Gran JT
    Tidsskr Nor Laegeforen; 1997 Feb; 117(4):517-8. PubMed ID: 9148450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) of hands and feet in an 83-year-old man.
    Nygaard U; Vestergaard C; Koppelhus U
    Acta Derm Venereol; 2013 Jul; 93(4):491-2. PubMed ID: 23306831
    [No Abstract]   [Full Text] [Related]  

  • 7. Remitting Seronegative Symmetrical Synovitis with Pitting Oedema (RS3PE) Syndrome in a Chronic Kidney Disease Patient Undzergoing Haemodialysis.
    Shindo M; Ishii H; Kitano T; Miyazawa H; Ito K; Ueda Y; Hirai K; Kaku Y; Hoshino T; Mori H; Ookawara S; Morishita Y
    Nephrology (Carlton); 2016 Dec; 21(12):1073. PubMed ID: 27870229
    [No Abstract]   [Full Text] [Related]  

  • 8. [RS3PE Syndrome: Remitting Seronegative Symmetrical Synovitis with Pitting Edema: A presentation of 3 cases].
    Fernández Silva MJ; Vilariño Méndez CR
    Semergen; 2012 Oct; 38(7):472-5. PubMed ID: 23021583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remitting seronegative symmetrical synovitis with pitting edema.
    Cho E; Kim MH
    Arch Dermatol; 2012 Oct; 148(10):1217-8. PubMed ID: 23069977
    [No Abstract]   [Full Text] [Related]  

  • 10. Synovitis with pitting edema as the presenting manifestation of systemic lupus erythematosus.
    Hegazi MO; Saleh F; Al Rashidi A; Yaktien MM
    Lupus; 2014 Sep; 23(10):1069-72. PubMed ID: 24786784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) during Nivolumab therapy for non-small cell lung cancer: a case report.
    Filetti M; Anselmi E; Macrini S; Rizzo F; Iacono D; Giusti R; Marchetti P
    Semin Arthritis Rheum; 2018 Oct; 48(2):e17-e20. PubMed ID: 29402438
    [No Abstract]   [Full Text] [Related]  

  • 12. Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis.
    Kawai M; Hagihara K; Hirano T; Shima Y; Kuwahara Y; Arimitsu J; Narazaki M; Ogata A; Kawase I; Kishimoto T; Tanaka T
    Rheumatology (Oxford); 2009 Mar; 48(3):318-9. PubMed ID: 19106169
    [No Abstract]   [Full Text] [Related]  

  • 13. Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome) showing dermatomyositis-like eruption.
    Takeda K; Fujita J; Fujii T; Tanabe H; Mochizuki T; Yanagihara M
    J Dermatol; 2010 Jan; 37(1):102-6. PubMed ID: 20175831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of remitting seronegative symmetrical synovitis with pitting edema complicated with Sjogren syndrome].
    Tanaka N; Nakano T; Isshiki K; Nagato Y; Tsujie M; Nakayama Y; Kakihara M; Yamada Y; Kamata T; Abe H
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1248-50. PubMed ID: 9379104
    [No Abstract]   [Full Text] [Related]  

  • 15. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome).
    Hung SC; Kung YY; Lin HY
    J Formos Med Assoc; 1999 Jul; 98(7):516-8. PubMed ID: 10463003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of tocilizumab, an anti-interleukin-6 receptor monoclonal antibody, in a patient with refractory GI graft-versus-host disease.
    Gergis U; Arnason J; Yantiss R; Shore T; Wissa U; Feldman E; Woodworth T
    J Clin Oncol; 2010 Oct; 28(30):e602-4. PubMed ID: 20713858
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody.
    Nishimoto N; Nakahara H; Yoshio-Hoshino N; Mima T
    Arthritis Rheum; 2008 Apr; 58(4):1197-200. PubMed ID: 18383395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase-4 inhibitor use is associated with a lower erythrocyte sedimentation rate in patients with remitting seronegative symmetrical synovitis with pitting oedema and pre-existing diabetes mellitus.
    Horai Y; Shimizu T; Okada A; Tokumitsu J; Ikeoka T; Kuriya G; Iwanaga N; Izumi Y; Origuchi T; Kawakami A
    Mod Rheumatol; 2022 Jul; 32(4):830-833. PubMed ID: 34908128
    [No Abstract]   [Full Text] [Related]  

  • 19. The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab.
    Shima Y; Kuwahara Y; Murota H; Kitaba S; Kawai M; Hirano T; Arimitsu J; Narazaki M; Hagihara K; Ogata A; Katayama I; Kawase I; Kishimoto T; Tanaka T
    Rheumatology (Oxford); 2010 Dec; 49(12):2408-12. PubMed ID: 20819796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interlukin-6 receptor inhibitor tocilizumab: a new treatment option in rheumatoid arthritis?
    Johnson J; Wang MY
    Neurosurgery; 2008 Aug; 63(2):N8. PubMed ID: 18797345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.